Evidence map›Paper›PMID 35225760›Full record

ArticleJournal of medical microbiology2022

First identification of

Joel Manyahi, Sabrina J Moyo, Upendo Kibwana, Richard N Goodman, Ellie Allman, Alasdair T M Hubbard, Bjørn Blomberg, Nina Langeland, Adam P Roberts

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Evidence of transmission and dissemination of diverseApplied and environmental microbiology · 2025
    Article
  8. Whole-genome analysis of extensively drug-resistantJAC-antimicrobial resistance · 2025
    Article
  9. Article
  10. Combined resistance mechanisms leading to high-level of cefiderocol resistance among NDM-like producing E. coli ST167 clinical isolates.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  11. Article
  12. Article
  13. Draft genome sequence of carbapenem resistantMicrobiology resource announcements · 2024
    Article
  14. Emergence of Carbapenem-Resistant UropathogenicPathogens (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Carbapenem-producingFrontiers in cellular and infection microbiology · 2024
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Joel ManyahiDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Sabrina J MoyoDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Upendo KibwanaDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, MUHAS, Dar es Salaam, Tanzania.
Richard N GoodmanDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.
Ellie AllmanDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.
Alasdair T M HubbardDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.
Bjørn BlombergDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Nina LangelandDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Adam P RobertsDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.
Liverpool School of Tropical Medicine · GBMuhimbili University of Health and Allied Sciences · TZHaukeland University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Escherichia coliEscherichia coli InfectionsHIV InfectionsAdultAnti-Bacterial Agentsbeta-LactamasesCarbapenemsHumansInfant, NewbornMicrobial Sensitivity TestsPlasmidsTanzaniaAnti-Bacterial Agentsbeta-LactamasesCarbapenemsblaNDM-5E. coliHIVneonatesTanzania

Identifiers

PMID35225760
PMCPMC8941953
OpenAlexW4214774581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.